Moderna saw some selling pressure today and moved down -3.80%
It looks like Moderna isn't currently at a very decisive point in regards to support/resistance levels. MRNA has been bouncing around but hasn't taken a very clear direction over the last few months. So it doesn't have very much obvious momentum in either direction. MRNA might find some support at the 117.34 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel fairly neutral on the prospects for Moderna but a little more positive than negative. The current Analysts Sentiment Score is 39.49. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Needham & Company LLC announced that they are reiterating a rating of Hold on 2024-03-28. Royal Bank of Canada announced that they are reiterating a rating of Outperform on 2024-03-28 and added a price target of $125.00. HSBC announced that they are reiterating a rating of Hold on 2024-02-26 and moved up their price target to $86.00 which is a 14.67% increase. On 2024-02-23 Canaccord Genuity Group increased their price target by 10.98% to $91.00. Oppenheimer upgraded from Market Perform to Outperform on 2024-01-02 and added a price target of $142.00. JPMorgan Chase & Co. provided a price target decease of -3.23% to $90.00 from $93.00 on 2023-12-01. On 2023-11-03 The Goldman Sachs Group lowered their price target by -14.13% to $231.00. On 2023-11-02 there was a downgrade announced by Deutsche Bank Aktiengesel from Hold to Sell and decided to decrease their price target by -52% down to $60.00. On 2023-09-13 Argus lowered their price target by -12.5% to $140.00. TD Cowen downgraded from Outperform to Market Perform on 2023-08-04 and decided to decrease their price target by -13.79% down to $125.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| MRNA | 39.49 | 105.64 | -71.88 | 75.6 | -30.38 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| MRNA | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| MRNA | 4.94 | %5.5 | 4.5 | -1.914 | 18050000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| MRNA |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX | BioNTech SE American Depo | 1.9 | -1.59 | -0.14 | -6.03 | -8.79 | -8.99 | -21.62 | 54 | -21.36 | -34.19 | -41.63 | -51470.08 | -1330.27 | 0 | 0 | 1.88302 |
| NVAX | Novavax Inc | 1.05 | -3.15 | 1.24 | -15.92 | 0.48 | -35.90 | -46.63 | 44 | -9.14 | -28.52 | -61.70 | -76812.22 | -836.90 | 0 | 0 | 23.8911 |
| ARCT | Arcturus Therapeutics Hol | 0.56 | -3.52 | 0.19 | -22.92 | -21.05 | 37.51 | -2.33 | 40 | 120.82 | 29.66 | 49.75 | -826.71 | -24011.65 | 0 | 0 | 17.9767 |
| CTLT | CATALENT, INC. | 0.54 | -0.13 | 0.72 | -1.01 | 8.21 | 41.72 | 27.78 | 37 | 82.98 | 26.97 | 39.70 | -47410.45 | -30366.90 | 0 | 0 | 4.97129 |
| RGEN | Repligen Corp | 0.53 | -1.50 | 5.22 | -10.10 | -12.71 | 32.88 | 11.23 | 38 | 72.03 | 22.91 | 32.20 | -1706.49 | 174.32 | 0 | 0 | 11.9373 |
| CVAC | CureVac N.V. Ordinary Sha | 0.53 | -10.96 | -8.40 | -26.24 | -37.74 | -59.58 | -69.26 | 42 | -275.86 | -79.80 | -97.00 | -129235.86 | -10.19 | 0 | 0 | 6.97988 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
